Analyst Ratings for AnaptysBio (ANAB)
ANAB Rating Summary
ANAB Price Target Summary
- Highest: $80.00 (Piper Sandler)
- Lowest: $20.00 (Truist Securities)
- Average: $44.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.56 (+131.2%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 60%
Avg. $ Target:
$44.56 (+131.2%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 60%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/16/2024 | Leerink Partners | David Risinger | New Coverage | Outperform (N/A) |
47.00 (N/A) |
21.27 (19.27) |
-9.4% | Details |
| 4/11/2024 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
56.00 (N/A) |
22.17 (19.27) |
-13.08% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
